WallStreetZenWallStreetZen
Analyst Ranking
Top 16%
#648 out of 4241 analysts
Average Return
+5.35%
Win Rate
53%39 out of 73
Risk vs Reward
Poor
Good

Tazeen Ahmad's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunomedics IncIMMU
+339.08%$20.01$87.86
2019-12-19 -
2020-10-22
Strong Buy
Argenx SeARGX
+133.81%$157.46$368.16
2020-02-09 -
2021-02-10
Strong Buy
Avexis IncAVXS
+127.40%$95.79$217.83
2017-11-09 -
2018-05-15
Strong Buy
Galera Therapeutics IncGRTX
+103.14%$1.59$3.23
2023-02-15 -
2023-06-09
Strong Buy
Acadia Pharmaceuticals IncACAD
+100.00%$20.24$40.48
2018-10-09 -
2019-10-10
Strong Buy

Tazeen Ahmad's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
4d Molecular Therapeutics IncFDMT
2Strong Buy$33.00+50.20%Maintains
3 days ago
Annexon IncANNX
2Hold$3.00+6.76%Downgrades
16 days ago
Ptc Therapeutics IncPTCT
8Sell$42.00-2.33%Maintains
17 days ago
Sage Therapeutics IncSAGE
10Strong Buy$61.00+2.45%Maintains
19 days ago
Acadia Pharmaceuticals IncACAD
7Hold$26.00+5.18%Maintains
20 days ago
Sarepta Therapeutics IncSRPT
1Strong Buy$176.00+37.86%Maintains
a month ago
Incyte CorpINCY
1Hold$84.00+37.61%Downgrades
a month ago
Adc Therapeutics SaADCT
2Sell$2.00-20.63%Downgrades
2 months ago
Ascendis Pharma AASND
5Strong Buy$92.00-0.71%Maintains
2 months ago
Biontech SeBNTX
5Strong Buy$194.00+77.57%Maintains
2 months ago
Amicus Therapeutics IncFOLD
1Strong Buy$17.00+32.71%Maintains
2 months ago
Galera Therapeutics IncGRTX
2Strong Buy$7.00+116.72%Upgrades
4 months ago
Cyteir Therapeutics IncCYT
1Hold$2.00-5.66%Downgrades
4 months ago
Fate Therapeutics IncFATE
1Sell$4.00-17.86%Downgrades
5 months ago
Sqz Biotechnologies CoSQZ
2Sell$2.00+270.37%Downgrades
6 months ago
Prelude Therapeutics IncPRLD
4Sell$6.00+10.70%Downgrades
7 months ago
Surrozen IncSRZN
3Sell$1.00+66.11%Downgrades
7 months ago
Cerevel Therapeutics Holdings IncCERE
1Strong Buy$39.00+18.79%Initiates Coverage On
8 months ago
Prothena Corp Public Ltd CoPRTA
2Strong BuyN/AN/AUpgrades
8 months ago
Pharvaris NvPHVS
2Sell$13.00+14.74%Downgrades
10 months ago
Rhythm Pharmaceuticals IncRYTM
4Hold$20.00+14.74%Upgrades
10 months ago
Praxis Precision Medicines IncPRAX
1Hold$4.00N/ADowngrades
a year ago
Pepgen IncPEPG
1Strong Buy$16.00N/AInitiates Coverage On
a year ago
Molecular Templates IncMTEM
1Sell$1.50N/ADowngrades
a year ago
Biocryst Pharmaceuticals IncBCRX
1Hold$14.00N/ADowngrades
a year ago
Pyxis Oncology IncPYXS
1Hold$16.00N/AInitiates Coverage On
2 years ago
Quince Therapeutics IncQNCX
1SellN/AN/ADowngrades
2 years ago
Arvinas IncARVN
1Strong Buy$110.00N/AInitiates Coverage On
2 years ago
Ultragenyx Pharmaceutical IncRARE
3Strong Buy$162.00N/AUpgrades
2 years ago
Akouos IncAKUS
2Hold$20.00N/ADowngrades
2 years ago
Orphazyme AORPHY
1Sell$5.00N/ADowngrades
2 years ago
Argenx SeARGX
2Strong Buy$298.00N/AMaintains
3 years ago
89bio IncETNB
1Strong Buy$43.00N/AUpgrades
3 years ago
Inozyme Pharma IncINZY
1Strong Buy$33.00N/AInitiates Coverage On
3 years ago
Fulcrum Therapeutics IncFULC
2Sell$11.00N/ADowngrades
3 years ago
Clovis Oncology IncCLVSQ
1Sell$6.00N/ADowngrades
3 years ago
Immunomedics IncIMMU
1Strong Buy$26.00N/AInitiates Coverage On
3 years ago
Dbv Technologies SaDBVT
1Strong Buy$30.00N/AMaintains
5 years ago
Tesaro IncTSRO
4Hold$39.00N/AMaintains
5 years ago
Spero Therapeutics IncSPRO
2Sell$9.00N/ADowngrades
5 years ago
Pacira Biosciences IncPCRX
3Hold$48.00N/AMaintains
5 years ago
Adamas Pharmaceuticals IncADMS
2Hold$25.00N/ADowngrades
5 years ago
Gw Pharmaceuticals PLCGWPH
3Strong Buy$200.00N/AMaintains
5 years ago
Ptc IncPTC
3Hold$102.00N/AMaintains
5 years ago
Neurocrine Biosciences IncNBIX
1Strong Buy$102.00N/AMaintains
5 years ago
Seagen IncSGEN
1Hold$68.00N/AMaintains
5 years ago
Avexis IncAVXS
1Strong Buy$112.00N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.